Finnish medtech Solid IO secures €800k investment to advance patient-specific tumor-on-chip technology
Solid IO develops a tumor-on-chip platform that replicates the patient’s tumor microenvironment, generating high-accuracy, real-time data on how individual cancers respond to immunotherapies and combination treatments.
